TTX-RIGA

N/A

Report date: 2023/10/19 14:00:55
NME

Base Information

Drug NameTTX-RIGA
Drug Alias NameTTX-RIGA
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRetinoic acid-inducible gene I stimulants
TargetsRetinoic acid-inducible gene I
Therapy Area/IndicationsMelanomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTransCode Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTransCode Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A